U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Tiotropium (marketed as Spiriva HandiHaler) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Tiotropium (marketed as Spiriva HandiHaler) Information

Spiriva HandiHaler is used for the treatment of breathing problems in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Spiriva is a maintenance bronchodilator. It helps to keep narrowed airways open. Spiriva does not treat sudden episodes of breathing problems (bronchospasm).

Labeling and Regulatory History from Drugs@FDA

Back to Top